eanNews
  • EAN News
    • All Executive Page President’s Corner EAN News EAN Congress news Interviews
      EAN Congress news

      Save the Dates: EAN Congress 2026 in Geneva, Switzerland, 27-30 June

      September 10, 2025

      Research Highlights

      Research Highlights of the Month – September 2025

      September 10, 2025

      Executive Page

      Executive Page: New Opportunities and Resources to Strengthen EAN’s Scientific Community in 2025–2026

      September 4, 2025

      President’s Corner

      President’s Corner – September 2025

      September 4, 2025

      Executive Page

      Executive Page: New Opportunities and Resources to Strengthen EAN’s Scientific Community in 2025–2026

      September 4, 2025

      Executive Page

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      Executive Page

      Executive Page: thank you for making the EAN Congress 2025 a great success!

      July 16, 2025

      Executive Page

      Executive Page: Get ready for EAN 2025 in Helsinki!

      June 3, 2025

      President’s Corner

      President’s Corner – September 2025

      September 4, 2025

      President’s Corner

      President’s Corner – August 2025

      August 12, 2025

      President’s Corner

      President’s Corner – July 2025

      July 16, 2025

      President’s Corner

      President’s Corner – June 2025

      June 3, 2025

      EAN News

      Research Highlights of the Month – September 2025

      September 10, 2025

      EAN News

      Executive Page: New Opportunities and Resources to Strengthen EAN’s Scientific Community in 2025–2026

      September 4, 2025

      EAN News

      President’s Corner – September 2025

      September 4, 2025

      EAN News

      Research Paper of the Month: Lithium deficiency and the onset of Alzheimer’s disease

      September 4, 2025

      EAN Congress news

      Save the Dates: EAN Congress 2026 in Geneva, Switzerland, 27-30 June

      September 10, 2025

      EAN Congress news

      An EAN Student Member’s experience at the EAN Congress – Helsinki 2025

      September 1, 2025

      EAN Congress news

      A Congress Highlight in Helsinki: Brain Health and Sustainability Booth

      August 28, 2025

      EAN Congress news

      Revisit the Highlights of EAN 2025 in Our Congress Review eBook

      July 24, 2025

      Interviews

      Video Interview: Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease, with Raphael Wurm

      March 14, 2025

      Interviews

      Video Interview: EMA approval of lecanemab, with Sebastiaan Engelborghs, EAN Dementia Panel Co-Chair

      January 15, 2025

      Interviews

      Video interview: Claudia Sommer, incoming Editor-in-Chief of the European Journal of Neurology

      January 3, 2025

      Interviews

      Video interviews: meet some of the EAN’s national neurological society partners!

      November 20, 2024

  • Research
    • All Paper of the Month Research Highlights Research Funding
      Research Highlights

      Research Highlights of the Month – September 2025

      September 10, 2025

      Paper of the Month

      Research Paper of the Month: Lithium deficiency and the onset of Alzheimer’s disease

      September 4, 2025

      Research

      EMA Neurology News – August 2025

      August 20, 2025

      Research Highlights

      Research Highlights of the Month – August 2025

      August 12, 2025

      Paper of the Month

      Research Paper of the Month: Lithium deficiency and the onset of Alzheimer’s disease

      September 4, 2025

      Paper of the Month

      Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

      August 12, 2025

      Paper of the Month

      Research Paper of the Month: Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation (CATALYST)

      July 16, 2025

      Paper of the Month

      Research Papers of the Month: Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease / Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease

      June 2, 2025

      Research Highlights

      Research Highlights of the Month – September 2025

      September 10, 2025

      Research Highlights

      Research Highlights of the Month – August 2025

      August 12, 2025

      Research Highlights

      Research Highlights of the Month – July 2025

      July 16, 2025

      Research Highlights

      Research Highlights of the Month – June 2025

      June 11, 2025

      Research Funding

      Draft Innovative Health Initiative (IHI) Funding Call topics related to the brain

      May 2, 2025

      Research Funding 'Horizon Europe' in large 3D text, surrounded by illustrations of people undertaking various activities

      Upcoming Horizon Europe Funding Opportunities for Neurology Researchers (Draft Calls)

      May 2, 2025

  • Education
    • All eLearning Mid-Career Resident and Research Fellows Student Corner Fellowship reports
      eLearning

      Join us for all-new Webinars in September!

      September 2, 2025

      EAN Congress news

      An EAN Student Member’s experience at the EAN Congress – Helsinki 2025

      September 1, 2025

      EAN News

      Shape the Future of EAN Panels – Apply to Join a Panel Management Group!

      September 1, 2025

      eLearning

      Join our Webinar on New challenges in Myasthenia Gravis in the Era of Innovative Treatments

      August 28, 2025

      eLearning

      Join us for all-new Webinars in September!

      September 2, 2025

      eLearning

      Join our Webinar on New challenges in Myasthenia Gravis in the Era of Innovative Treatments

      August 28, 2025

      eLearning

      Join our Webinar on Multidisciplinary Perspectives on aTTR Amyloidosis: From Nerves to Heart

      August 21, 2025

      eLearning

      Call for Applications: eanCampus Associate Editors

      July 1, 2025

      Mid-Career

      Certificate of Advanced Studies (CAS) in Brain Health starts second round in January 2026

      August 25, 2025

      Mid-Career

      First 20 EAN Leadership Programme participants graduate, as second group gets underway

      July 10, 2025

      Mid-Career

      Empowering growth: my journey through the EAN Leadership Programme

      March 14, 2025

      Mid-Career

      Join the EAN Congress Masterclass in Vienna!

      January 20, 2025

      Resident and Research Fellows

      Shape the Future of EAN Panels – Apply to Join a Panel Management Group!

      September 1, 2025

      Resident and Research Fellows

      Sign up for the 5th EAN Science School, 13-17 March, 2026

      August 20, 2025

      Resident and Research Fellows

      EAN Regional Teaching Day in Riga, Latvia – 6 November 2025

      August 13, 2025

      Resident and Research Fellows

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      Student Corner

      An EAN Student Member’s experience at the EAN Congress – Helsinki 2025

      September 1, 2025

      Student Corner

      Student Teaser Fellowships winners 2025

      June 6, 2025

      Student Corner Photo of a sheet of paper, pencil and crumpled paper on a desk.

      Why Neurology? Read some compelling answers from our EAN 2025 essay contest winners!

      May 12, 2025

      Student Corner

      Student Teaser Fellowship reports 2023 – Paris & Basel

      March 12, 2025

      Fellowship reports

      Research Fellowship Reports 2023: Lyon, Berlin, & London

      March 31, 2025

      Fellowship reports

      Student Teaser Fellowship reports 2023 – Paris & Basel

      March 12, 2025

      Fellowship reports

      Clinical Fellowship Reports 2023: Utrecht, Dianalund, & London

      February 20, 2025

      Fellowship reports

      Research Fellowship Reports 2023: London & Vienna/Paris

      October 8, 2024

  • Other News
    • All EAN Staff EBC News in general Surveys
      Advocacy

      Why do Placebo and Nocebo Effects Matter? – Improving the Education of Healthcare Professionals | 5 November 2025

      August 21, 2025

      Other News

      EAN Panel Management Group Member Discusses Palliative Care on OneNeurology Podcast Marking World Brain Day

      August 8, 2025

      Other News

      Empowering the HD Community: The Launch of the Huntington Academy

      July 10, 2025

      Advocacy

      EAN TV | National Brain Plans and the Path Toward EU Coordination: Insights from Finland and Europe

      June 21, 2025

      EAN Staff

      EAN Head Office Profiles: Ulla & Piyapat

      December 1, 2023

      EAN Staff

      EAN Head Office Profiles: Kathrin & Sasha

      August 28, 2023

      EAN Staff Anja Sander receiving flowers at the end of EAN Congress 2023

      Celebrating 20 Years of Excellence: Anja Sander, EAN’s Executive Director!

      August 3, 2023

      EAN Staff

      EAN Head Office Profiles: Dauren & Benita

      June 5, 2023

      EBC

      EAN TV | National Brain Plans and the Path Toward EU Coordination: Insights from Finland and Europe

      June 21, 2025

      EBC

      EAN TV | European Brain Council: Paving the Way for a European Brain Health Partnership

      June 21, 2025

      EBC Composite image containing various photos from European Brain Council events, plus the EBC logo

      EBC launches 2024 annual report

      April 25, 2025

      EBC

      Brain Innovation Days announces theme and subtheme for 2025 edition!

      March 29, 2025

      News in general

      New paper offers insight into patient involvement in neurological research 

      January 31, 2025

      News in general

      Join the European Brain Council’s ‘Towards a Rare Brain Disease Ecosystem’ event in Brussels on 20 February!

      January 31, 2025

      News in general

      The Brain Prize 2024: Pioneering work in computational and theoretical neuroscience is awarded the world’s largest brain research prize

      March 5, 2024

      News in general

      WHO’s Intersectoral Global Action Plan on epilepsy and other neurological disorders (IGAP) published in all six UN languages

      August 3, 2023

      Surveys

      Public Consultation – European Charter for the Responsible Development of Neurotechnologies

      November 25, 2024

      Surveys

      A survey on connectomics: key insights from EAN neurologists

      July 25, 2024

      Surveys

      Survey: Mapping European Neurological Programs in Solid Organ Transplant Centers

      May 31, 2024

      Surveys

      Neurorehabilitation Across Europe after Ischemic and Traumatic Brain Injuries: a survey to increase knowledge on brain-injury-specific neurorehabilitation

      July 14, 2023

  • EAN
  • Congress 2026
  • eanNews
  • eanCampus
  • Eur J Neurol
  • Brain Health Mission

eanNews

  • EAN News
    • All Executive Page President’s Corner EAN News EAN Congress news Interviews
      EAN Congress news

      Save the Dates: EAN Congress 2026 in Geneva, Switzerland, 27-30 June

      September 10, 2025

      Research Highlights

      Research Highlights of the Month – September 2025

      September 10, 2025

      Executive Page

      Executive Page: New Opportunities and Resources to Strengthen EAN’s Scientific Community in 2025–2026

      September 4, 2025

      President’s Corner

      President’s Corner – September 2025

      September 4, 2025

      Executive Page

      Executive Page: New Opportunities and Resources to Strengthen EAN’s Scientific Community in 2025–2026

      September 4, 2025

      Executive Page

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      Executive Page

      Executive Page: thank you for making the EAN Congress 2025 a great success!

      July 16, 2025

      Executive Page

      Executive Page: Get ready for EAN 2025 in Helsinki!

      June 3, 2025

      President’s Corner

      President’s Corner – September 2025

      September 4, 2025

      President’s Corner

      President’s Corner – August 2025

      August 12, 2025

      President’s Corner

      President’s Corner – July 2025

      July 16, 2025

      President’s Corner

      President’s Corner – June 2025

      June 3, 2025

      EAN News

      Research Highlights of the Month – September 2025

      September 10, 2025

      EAN News

      Executive Page: New Opportunities and Resources to Strengthen EAN’s Scientific Community in 2025–2026

      September 4, 2025

      EAN News

      President’s Corner – September 2025

      September 4, 2025

      EAN News

      Research Paper of the Month: Lithium deficiency and the onset of Alzheimer’s disease

      September 4, 2025

      EAN Congress news

      Save the Dates: EAN Congress 2026 in Geneva, Switzerland, 27-30 June

      September 10, 2025

      EAN Congress news

      An EAN Student Member’s experience at the EAN Congress – Helsinki 2025

      September 1, 2025

      EAN Congress news

      A Congress Highlight in Helsinki: Brain Health and Sustainability Booth

      August 28, 2025

      EAN Congress news

      Revisit the Highlights of EAN 2025 in Our Congress Review eBook

      July 24, 2025

      Interviews

      Video Interview: Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease, with Raphael Wurm

      March 14, 2025

      Interviews

      Video Interview: EMA approval of lecanemab, with Sebastiaan Engelborghs, EAN Dementia Panel Co-Chair

      January 15, 2025

      Interviews

      Video interview: Claudia Sommer, incoming Editor-in-Chief of the European Journal of Neurology

      January 3, 2025

      Interviews

      Video interviews: meet some of the EAN’s national neurological society partners!

      November 20, 2024

  • Research
    • All Paper of the Month Research Highlights Research Funding
      Research Highlights

      Research Highlights of the Month – September 2025

      September 10, 2025

      Paper of the Month

      Research Paper of the Month: Lithium deficiency and the onset of Alzheimer’s disease

      September 4, 2025

      Research

      EMA Neurology News – August 2025

      August 20, 2025

      Research Highlights

      Research Highlights of the Month – August 2025

      August 12, 2025

      Paper of the Month

      Research Paper of the Month: Lithium deficiency and the onset of Alzheimer’s disease

      September 4, 2025

      Paper of the Month

      Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

      August 12, 2025

      Paper of the Month

      Research Paper of the Month: Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation (CATALYST)

      July 16, 2025

      Paper of the Month

      Research Papers of the Month: Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease / Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease

      June 2, 2025

      Research Highlights

      Research Highlights of the Month – September 2025

      September 10, 2025

      Research Highlights

      Research Highlights of the Month – August 2025

      August 12, 2025

      Research Highlights

      Research Highlights of the Month – July 2025

      July 16, 2025

      Research Highlights

      Research Highlights of the Month – June 2025

      June 11, 2025

      Research Funding

      Draft Innovative Health Initiative (IHI) Funding Call topics related to the brain

      May 2, 2025

      Research Funding 'Horizon Europe' in large 3D text, surrounded by illustrations of people undertaking various activities

      Upcoming Horizon Europe Funding Opportunities for Neurology Researchers (Draft Calls)

      May 2, 2025

  • Education
    • All eLearning Mid-Career Resident and Research Fellows Student Corner Fellowship reports
      eLearning

      Join us for all-new Webinars in September!

      September 2, 2025

      EAN Congress news

      An EAN Student Member’s experience at the EAN Congress – Helsinki 2025

      September 1, 2025

      EAN News

      Shape the Future of EAN Panels – Apply to Join a Panel Management Group!

      September 1, 2025

      eLearning

      Join our Webinar on New challenges in Myasthenia Gravis in the Era of Innovative Treatments

      August 28, 2025

      eLearning

      Join us for all-new Webinars in September!

      September 2, 2025

      eLearning

      Join our Webinar on New challenges in Myasthenia Gravis in the Era of Innovative Treatments

      August 28, 2025

      eLearning

      Join our Webinar on Multidisciplinary Perspectives on aTTR Amyloidosis: From Nerves to Heart

      August 21, 2025

      eLearning

      Call for Applications: eanCampus Associate Editors

      July 1, 2025

      Mid-Career

      Certificate of Advanced Studies (CAS) in Brain Health starts second round in January 2026

      August 25, 2025

      Mid-Career

      First 20 EAN Leadership Programme participants graduate, as second group gets underway

      July 10, 2025

      Mid-Career

      Empowering growth: my journey through the EAN Leadership Programme

      March 14, 2025

      Mid-Career

      Join the EAN Congress Masterclass in Vienna!

      January 20, 2025

      Resident and Research Fellows

      Shape the Future of EAN Panels – Apply to Join a Panel Management Group!

      September 1, 2025

      Resident and Research Fellows

      Sign up for the 5th EAN Science School, 13-17 March, 2026

      August 20, 2025

      Resident and Research Fellows

      EAN Regional Teaching Day in Riga, Latvia – 6 November 2025

      August 13, 2025

      Resident and Research Fellows

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      Student Corner

      An EAN Student Member’s experience at the EAN Congress – Helsinki 2025

      September 1, 2025

      Student Corner

      Student Teaser Fellowships winners 2025

      June 6, 2025

      Student Corner Photo of a sheet of paper, pencil and crumpled paper on a desk.

      Why Neurology? Read some compelling answers from our EAN 2025 essay contest winners!

      May 12, 2025

      Student Corner

      Student Teaser Fellowship reports 2023 – Paris & Basel

      March 12, 2025

      Fellowship reports

      Research Fellowship Reports 2023: Lyon, Berlin, & London

      March 31, 2025

      Fellowship reports

      Student Teaser Fellowship reports 2023 – Paris & Basel

      March 12, 2025

      Fellowship reports

      Clinical Fellowship Reports 2023: Utrecht, Dianalund, & London

      February 20, 2025

      Fellowship reports

      Research Fellowship Reports 2023: London & Vienna/Paris

      October 8, 2024

  • Other News
    • All EAN Staff EBC News in general Surveys
      Advocacy

      Why do Placebo and Nocebo Effects Matter? – Improving the Education of Healthcare Professionals | 5 November 2025

      August 21, 2025

      Other News

      EAN Panel Management Group Member Discusses Palliative Care on OneNeurology Podcast Marking World Brain Day

      August 8, 2025

      Other News

      Empowering the HD Community: The Launch of the Huntington Academy

      July 10, 2025

      Advocacy

      EAN TV | National Brain Plans and the Path Toward EU Coordination: Insights from Finland and Europe

      June 21, 2025

      EAN Staff

      EAN Head Office Profiles: Ulla & Piyapat

      December 1, 2023

      EAN Staff

      EAN Head Office Profiles: Kathrin & Sasha

      August 28, 2023

      EAN Staff Anja Sander receiving flowers at the end of EAN Congress 2023

      Celebrating 20 Years of Excellence: Anja Sander, EAN’s Executive Director!

      August 3, 2023

      EAN Staff

      EAN Head Office Profiles: Dauren & Benita

      June 5, 2023

      EBC

      EAN TV | National Brain Plans and the Path Toward EU Coordination: Insights from Finland and Europe

      June 21, 2025

      EBC

      EAN TV | European Brain Council: Paving the Way for a European Brain Health Partnership

      June 21, 2025

      EBC Composite image containing various photos from European Brain Council events, plus the EBC logo

      EBC launches 2024 annual report

      April 25, 2025

      EBC

      Brain Innovation Days announces theme and subtheme for 2025 edition!

      March 29, 2025

      News in general

      New paper offers insight into patient involvement in neurological research 

      January 31, 2025

      News in general

      Join the European Brain Council’s ‘Towards a Rare Brain Disease Ecosystem’ event in Brussels on 20 February!

      January 31, 2025

      News in general

      The Brain Prize 2024: Pioneering work in computational and theoretical neuroscience is awarded the world’s largest brain research prize

      March 5, 2024

      News in general

      WHO’s Intersectoral Global Action Plan on epilepsy and other neurological disorders (IGAP) published in all six UN languages

      August 3, 2023

      Surveys

      Public Consultation – European Charter for the Responsible Development of Neurotechnologies

      November 25, 2024

      Surveys

      A survey on connectomics: key insights from EAN neurologists

      July 25, 2024

      Surveys

      Survey: Mapping European Neurological Programs in Solid Organ Transplant Centers

      May 31, 2024

      Surveys

      Neurorehabilitation Across Europe after Ischemic and Traumatic Brain Injuries: a survey to increase knowledge on brain-injury-specific neurorehabilitation

      July 14, 2023

Paper of the MonthFeatured Slider

Paper of the month: Idarucizumab to antagonize thrombin inhibitor dabigatran

May 1, 2017

 

 

By Elena Moro

 

For May 2017 we have selected: Kermer P, Eschenfelder CC, Diener H-C, et al.  Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany – A national case collection. International Journal of Stroke 2017; doi: 10.1177/1747493017701944.

 

The use of non-vitamin-K-antagonist oral anticoagulants (NOACs) to prevent stroke in patients with atrial fibrillation is increasing worldwide. Compared to warfarin, NOACs seem to have less hemorrhagic complications, including intracranial hemorrhage. However, specific rapid reversal agents for NOACS are still lacking. Between the four NOACs available, dabigatran has shown to be superior to warfarin for stroke prevention, and it has the advantage to be quickly antagonized by idarucizumab in case of uncontrolled bleeding or other emergencies. Idarucizumab is a humanized Fab fragment of a monoclonal antibody able to bind dabigatran with high affinity. However, available data on the use of this antagonist in patients with acute stroke who need thrombolysis are still anecdotal.

In this retrospective German multicenter study, the authors report on the national experience with idarucizumab in dabigatran-treated patients with acute stroke or intracranial bleeding since the availability of the drug, January 2016, to August 2016. Collected data included baseline clinical characteristics, clinical findings, coagulation and other laboratory parameters, imaging, clinical course, etcetera.  For the hemorrhagic group of patients, further data about size and hematoma growth, idarucizumab adverse events, and modified Rankin score (mRS) outcomes were obtained. For the ischemic stroke group of patients, information about the NIHSS, mRS, bleedings and thrombotic complications were included. Full data were available in 31 patients, 19 with ischemic stroke, and 12 with intracranial bleeding.

Between the ischemic stroke patents, 18 were eligible to systemic thrombolysis within the 4.5-hour window. Most patients were receiving 110 mg bid dabigatran for atrial fibrillation. The partial thromboplastin time (aPTT) was normal in 13 patients, whereas the thrombin time (TT) was abnormal in 11 patients at admission. All patients received idarucizumab, which normalized the coagulation parameters, and allowed rt-PA administration. One patient had also additional thrombectomy. Improvement after thrombolysis was observed in 15 patients, who gained 5 points in the NIHSS as median. Anticoagulant therapy was restarted between 10 days after stroke in 74% of patients. Two patients did not recover: one had signs of acute severe vertebrobasilar stroke, and the other died five days after treatment due to pneumonia and pulmonary embolism.

Between the patients with intracranial bleeding, 8 had intracranial hemorrhage, 3 had subdural hematoma, and 1 subarachnoidal bleeding. All had atrial fibrillation. TT was elevated at admission in 9 patients. After idarucizimab administration, no hematoma grow was observed in 10 patients. The median NIHSS improved of 5.5 points. One patient presenting with massive bleeding at admission died.

“Although the study has obvious limitations such as the retrospective nature and the small number of patients, its findings are relevant to clinical practice, especially in emergency settings when intravenous thrombolysis is indicated. Idarucizimab has shown to be safe and efficacious in reversing dabigatran anticoagulant effects”, says Prof Thierry Moulin, Division of Neurology, Besancon, France.

“Idarucizimab seems to be effective also in limiting the expansion of intracranial bleedings in patients taking dabigatran. This effect might have an important role in reducing mortality and improve the outcome. Therefore, idarucizimab should be used in all patients with hemorrhagic stroke or intracranial hemorrhages”, says Prof. Hans-Christoph Diener, Department of Neurology, Essen, Germany.

The other nominees for the May paper of the month are:

  1. Perry JR, Laperriere N, O’Callaghan CJ, et al., for the Trial Investigators.Short-course radiation plus temozolomide in elderly patients with glioblastoma. N Engl J Med 2017;376:1027-1037. The effect on survival of short-course radiotherapy alone vs. short-course radiotherapy plus temozolomide was studied in 562 glioblastoma patients 65 years of age or older. The group with temozolomide (281 patients) showed longer survival compared to the other group (9.3 months vs. 7.6 months). Moreover, patients with methylated O6-methylguanine–DNA methyltransferase status (189 patients) who had temozolomide presented with 13.5 months’ survival compared to 7.7 months in the patients with radiotherapy alone.
  2. Mathieson S, Maher CG, McLachlan AJ, et al. Trial of pregabalin for acute and chronic sciatica. N Engl J Med 2017;376:1111-1120. In this randomized, double-blind, placebo controlled trial, the effectiveness of pregabalin to improve pain was assessed in patients with sciatica. Neither at 8 nor at 52 weeks pregabalin (up to 600 mg/day) could significantly reduce leg pain (108 patients) vs. placebo (101 patients). Moreover, adverse events were significantly higher in the active drug group.
  3. Xin Y, O’Brien EC, Liang L, et al. Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation. JAMA 2017;317:1057-1067. This retrospective US observational study analyzed the prevalence of patients with atrial fibrillation and no or not effective antithrombotic treatment who had acute ischemic stroke, compared to patients under therapeutic antithrombotic treatment. Data were collected from 94,474 patients admitted to hospitals within a 2.5-year period. About 84% of these patients were not receiving therapeutic anticoagulation. The unadjusted rates of moderate or severe stroke and in-hospital mortality were lower among patients receiving therapeutic anticoagulants.
  4. Zakrzewska JM, Palmer J, Morisset V, et al., for the Study Investigators. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. Lancet Neurol 2017;16:291-300. Safety and efficacy of a new Nav.17 selective sodium channel blocker, BIIB074, to treat trigeminal neuralgia were studied in a multicenter study involving a total of 67 patients. During the double-blind phase (15 patients with BIIB074 and 14 with placebo) there was no significant difference in treatment failures between groups. BIIB074 was well tolerated.

 

Paper of the month: Idarucizumab to antagonize thrombin inhibitor dabigatran was last modified: November 13th, 2018 by Editor
Share this...
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
Linkedin
ischemic strokenon-vitamin-K-antagonist oral anticoagulantsNOACsfibrillationradiotherapy
previous post
Country of the Month: Romania
next post
President’s Page: ICD 11 will finally classify stroke as a neurological disease

You may also like

Executive Page: New Opportunities and Resources to Strengthen EAN’s Scientific Community in 2025–2026

September 4, 2025

President’s Corner – September 2025

September 4, 2025

Research Paper of the Month: Lithium deficiency and the onset of Alzheimer’s disease

September 4, 2025

Executive Page: the RRFS is here to support you – and help shape the future of European neurology

August 12, 2025

President’s Corner – August 2025

August 12, 2025

Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

August 12, 2025

Executive Page: thank you for making the EAN Congress 2025 a great success!

July 16, 2025

President’s Corner – July 2025

July 16, 2025

Research Paper of the Month: Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation (CATALYST)

July 16, 2025

EAN 2025 Presidential Symposium: bridging neuroscience frontiers from theory to clinical impact

June 22, 2025

Leave a Comment Cancel Reply

You need to be logged in to comment. Please login to MyEAN on top.

Upcoming Events

Sep
15
Mon
all-day The XXIII Nordic Stroke Society ...
The XXIII Nordic Stroke Society ...
Sep 15 – Sep 17 all-day
The XXIII Nordic Stroke Society Congress
  23rd Nordic Congress on Cerebrovascular Diseases is held in Tartu, Estonia on September 15-17, 2025. Participants and abstracts are welcome from all countries and specialities to continue the valuable…
6:00 pm EAN Webinar: Multidisciplinary P...
EAN Webinar: Multidisciplinary P...
Sep 15 @ 6:00 pm – 7:30 pm
  This EAN webinar will explore the neurological and cardiac perspectives of aTTR amyloidosis, offering insights into diagnosis, clinical challenges, and emerging therapies. We invite you to be part of…
Sep
24
Wed
all-day 41st Congress of the European Co...
41st Congress of the European Co...
Sep 24 – Sep 26 all-day
41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
  41-th Congress of ECTRIMS will be held from 24-26 September, in Barcelona at the CCIB Barcelona International Convention Center. This year’s programme offers top-tier scientific sessions, education, networking, and…
all-day The 21st EuGMS Congress
The 21st EuGMS Congress
Sep 24 – Sep 26 all-day
The 21st EuGMS Congress
    The 21st EuGMS Congress is coming to Reykjavik, Iceland 🇮🇸, on September 24-26, 2025! Under the theme “New landscapes in geriatric medicine”, this congress will bring together experts…
Sep
25
Thu
all-day European Huntington’s Associatio... @ Ramada Plaza by Wyndham Bucharest Convention Center,
European Huntington’s Associatio... @ Ramada Plaza by Wyndham Bucharest Convention Center,
Sep 25 – Sep 28 all-day
European Huntington's Association 5th Biennal Conference - Bucharest, Romania @ Ramada Plaza by Wyndham Bucharest Convention Center,
The European Huntington Association is thrilled to announce its 5th Biennial Conference, taking place in Bucharest, Romania, from 25–28 September 2025. Under the theme “Shaping our Future Together, We are the Change!”, the…
View Calendar

Keep in touch

Facebook Instagram Linkedin
EAN Pages is a members service of the European Academy of Neurology https://www.ean.org

All content from January 2012 - June 2013 was published by EFNS; content from July 2013 - June 2014 by EFNS and ENS.

ISSN 2310-2934

Keep in touch

Facebook Instagram Linkedin

Archives

Pages

  • Privacy Policy
  • About us
  • Help

Back To Top